References

On-line aSi portal imaging of implanted fiducial markers for the reduction of interfraction error during conformal radiotherapy of prostate carcinoma

10.1016/j.ijrobp.2004.03.038 · 2004 · External reference

Analysis of prostate and seminal vesicle motion: implications for treatment planning

10.1016/0360-3016(95)02081-0 · 1996 · External reference

Influence of rectal volume changes during radiotherapy for prostate cancer: a predictive model for mild-to-moderate late rectal toxicity

10.1016/s0360-3016(03)00749-1 · 2003 · External reference

Evaluation of changes in the size and location of the prostate, seminal vesicles, bladder, and rectum during a course of external beam radiation therapy

10.1016/0360-3016(95)00225-1 · 1995 · External reference

Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy

10.1016/j.ijrobp.2004.11.032 · 2005 · External reference

Dosimetric implications of changes in patient repositioning and organ motion in conformal radiotherapy for prostate cancer

10.1016/s0167-8140(02)00368-7 · 2003 · External reference

Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial

10.1001/jama.294.10.1233 · 2005 · External reference

Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial

10.1016/s1470-2045(07)70143-2 · 2007 · External reference

Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer

10.1016/j.ijrobp.2007.06.054 · 2008 · External reference

Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial

10.1016/s0360-3016(02)02829-8 · 2002 · External reference

Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy

10.1016/j.ijrobp.2004.07.715 · 2005 · External reference

Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects

10.1038/sj.bjc.6602301 · 2005 · External reference

Quantification of organ motion during conformal radiotherapy of the prostate by three dimensional image registration

10.1016/0360-3016(95)00116-6 · 1995 · External reference

Emptying the rectum before treatment delivery limits the variations of rectal dose-volume parameters during 3DCRT of prostate cancer

10.1016/j.radonc.2006.08.007 · 2006 · External reference

Qualitative estimation of pelvic organ interactions and their consequences on prostate motion: study on a deceased person

10.1118/1.2198190 · 2006 · External reference

Comparison of megavoltage position verification for prostate irradiation based on bony anatomy and implanted fiducials

10.1016/s0167-8140(03)00129-4 · 2003 · External reference

Positioning errors and prostate motion during conformal prostate radiotherapy using on-line isocentre set-up verification and implanted prostate markers

10.1016/s0167-8140(01)00452-2 · 2001 · External reference

Marker seed migration in prostate localization

10.1016/s0360-3016(03)00328-6 · 2003 · External reference

A review of prostate motion with considerations for the treatment of prostate cancer

10.1016/j.meddos.2005.03.005 · 2005 · External reference

Evaluating the effect of rectal distension and rectal movement on prostate gland position using cine MRI

10.1016/s0360-3016(99)00040-1 · 1999 · External reference

Quantification and predictors of prostate position variability in 50 patients evaluated with multiple CT scans during conformal radiotherapy

10.1016/s0167-8140(99)00011-0 · 1999 · External reference

Variation in prostate position quantitation and implications for three-dimensional conformal treatment planning

10.1016/s0360-3016(97)00221-6 · 1997 · External reference

Variation in volumes, dose-volume histograms, and estimated normal tissue complication probabilities of rectum and bladder during conformal radiotherapy of T3 prostate cancer

10.1016/0360-3016(95)00253-7 · 1995 · External reference

Treatment planning issues related to prostate movement in response to differential filling of the rectum and bladder

10.1016/0360-3016(91)90244-x · 1991 · External reference

Prostate motion during standard radiotherapy as assessed by fiducial markers

10.1016/0167-8140(95)01613-l · 1995 · External reference

Prostate target volume variations during a course of radiotherapy

10.1016/s0360-3016(98)00248-x · 1998 · External reference

Prostate position late in the course of external beam therapy: patterns and predictors

10.1016/s0360-3016(00)00469-7 · 2000 · External reference